Argus Research Maintains Buy on Herbalife, Raises Price Target to $20
Benzinga Newsdesk 6 hours ago
Analyst RatingsNewsPrice Target
Argus Research analyst John Staszak maintains Herbalife (NYSE:HLF) with a Buy and raises the price target from $15 to $20.
Argus Research analyst John Staszak maintains Herbalife (NYSE:HLF) with a Buy and raises the price target from $15 to $20.